Biobanks Market Size Worth $74.54 Billion by 2025 | CAGR 4.5%: Grand View Research, Inc.

News provided by

Nov 28, 2018, 06:05 ET

SAN FRANCISCO, November 28, 2018 /PRNewswire/ --

The global biobanks market size is expected to reach USD 74.54 billion by 2025 at a 4.5% CAGR over the forecast period, according to a new report by Grand View Research, Inc. Growing need for sample collection to support and facilitate clinical trials for novel therapies, which are developed for treatment of chronic conditions, is anticipated to boost the market.

(Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg )

Different biospecimens stored at biobanks are witnessing significant demand owing to advancements in cell-based research activities. Rising demand from different end users has led to establishment of a substantial number of population-based and disease-based banks in recent years. Population-based banks are established to support precision medicine research initiatives, whereas disease-specific biobanks provide resources to research communities to enable a better understanding of disease etiology.

Furthermore, there has been a rapid increase in number of biobanks over the recent past, which can be attributed to perpetual developments in cell-based therapies, such as advent of stem cells and regenerative medicine. Thus, competition among biobanks is observed within for-profit biostorage entities that provide open access to researchers and hospitals. Increase in efforts undertaken by life science industries for collaboration with biobanks to support life science research programs is expected to further boost the market.

In addition, regional biobank networks are being established to enhance accessibility to biospecimens and promote international sharing of these samples. Few examples of such networks are BBMIR-ERIC, Asian Network of Research Resource Centers, and Asian Consortium for the Conservation and Sustainable Use of Microbial Resources.

Increase in number of clinical trials for new drug candidates has spurred demand for biobanking services. Major challenges in biobanking operations include sustainability, limited access, and information sharing. However, technology advancements aid in overcoming these hurdles. Owing to introduction of novel applications of stored cells and biospecimens in drug development, leading economies such as U.S. and U.K. are revising their regulatory policies and guidelines pertaining to biobanking operations.

Browse full research report with TOC on "Biobanks Market Size, Share & Trends Analysis Report By Product (LIMS), By Service (Cold Chain), By Biospecimen Type, By Biobank Type (Virtual), By Application, And Segment Forecasts, 2018 - 2025" at: https://www.grandviewresearch.com/industry-analysis/biobanks-industry

Further Key Findings From the Report Suggest:

Biobanking equipment held the dominant share by product in 2017. High cost of equipment, coupled with rapid increase in number of biobanks, is attributive to its leading revenue share
The LIMS segment is projected to witness lucrative growth over the forecast period owing to rise in efforts undertaken for improvement of sample quality to suit international standards
North America dominated the global market in 2017 owing to high demand for biosamples. This increase in demand is attributive to rapid advancement of genomics, bioinformatics, and translational research
Asia Pacific is projected to exhibit the fastest growth due to rapid progress of Asian countries in healthcare, drug discovery, and scientific research
Some of the major companies offering biobanking products are QIAGEN; Thermo Fisher Scientific Inc.; Agilent Technologies, Inc.; and Merck KGaA. VMR International, Charles River, Lonza, Biovault, Thermo Fisher Scientific (Fisher BioServices), and Virgin Health Bank are among prominent companies engaged in offering biobanking services.

Browse related reports by Grand View Research:

Molecular Biology Enzymes And Kits & Reagents Market - The global Molecular Biology Enzymes And Kits & Reagents market size was valued at USD 5.77 billion in 2016

Transplantation Market - The global transplantation market size was estimated at USD 23.5 billion in 2016.

Cancer Biomarker Market - The global cancer biomarker market size was valued at USD 10.3 billion in the year 2016 and is estimated to reach a value of USD 33.7 billion by 2025, growing with CAGR of 14.3 %.

Pharmaceutical Filtration Market - The global pharmaceutical filtration market size was estimated at USD 13.7 billion in 2016

Grand View Research has segmented the global biobanks market on the basis of product, service, biospecimen type, biobank type, application, and region:

Biobanks Product Outlook (Revenue, USD Million, 2014 - 2025)
- Biobanking Equipment
  - Temperature Control Systems
    - Freezers & Refrigerators
    - Cryogenic Storage Systems
    - Thawing Equipment
  - Incubators & Centrifuges
  - Alarms & Monitoring Systems
  - Accessories & Other Equipment
- Biobanking Consumables
- Laboratory Information Management Systems
Biobanks Service Outlook (Revenue, USD Million, 2014 - 2025)
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
Biobanks Biospecimen Type Outlook (Revenue, USD Million, 2014 - 2025)
- Human Tissues
- Organs
- Stem Cells
  - Adult Stem Cells
  - Embryonic Stem Cells
  - IPS Cells
  - Other Stem Cells
- Other Biospecimens
Biobanks Type Outlook (Revenue, USD Million, 2014 - 2025)
- Physical/Real Biobanks
  - Tissue Biobanks
  - Population Based Biobanks
  - Genetic (DNA/RNA)
  - Disease Based Biobanks
- Virtual Biobanks
Biobanks Application Outlook (Revenue, USD Million, 2014 - 2025)
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
Biobanks Regional Outlook (Revenue, USD Million, 2014 - 2025)
- North America
  - U.S.
  - Canada
- Europe
  - Germany
  - U.K.
- Asia Pacific
  - Japan
  - China
- Latin America
  - Brazil
- Middle East & Africa
  - South Africa

Explore the BI enabled intuitive market research database, Grand View Compass, by Grand View Research, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]

Web: https://www.grandviewresearch.com

SOURCE Grand View Research, Inc.